UnknownNot Applicable

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

Sweden104 participantsStarted 2022-10

Plain-language summary

This study focuses on the treatment of benign prostatic hyperplasia which causes lower urinary tract symptoms. The purpose of the research project is to evaluate PAE in terms of both medical and health economic outcomes. To evaluate whether there are any differences in effect (IPSS), complications, costs and perceived quality of life compared with TUR-P.

Who can participate

Age range45 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Benign prostatic hyperplasia where medical treatment has not helped or for other reasons has not been deemed applicable * IPSS\>=8 * Prostate volume \[40-80\] ml measured via transrectal ultrasound * Peak flow rate (Qmax) \<= 15 ml / s, * Verified obstruction by urodynamic studies (cystometry) * Surgery not contraindicated Exclusion Criteria: * Prostate cancer * Severe atherosclerosis * Kidney failure * Urethral stricture * Active cystitis or prostatitis * Bladder stone. * Neurogenic bladder disorder * Contrast product allergy

What they're measuring

Improvement of lower urinary tract symptoms

Timeframe: 24 months

Health care costs

Timeframe: 24 months

Trial details

NCT IDNCT05531240

SponsorUppsala University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12

Contact for this trial

Emir Majbar, MD

+4621173000 emir.majbar@regionvastmanland.se

View on ClinicalTrials.gov More Transurethral Resection of Prostate Syndrome trials